Microarray analysis of polychlorinated biphenyl mixture-induced changes in gene expression among atlantic tomcod populations displaying differential sensitivity to halogenated aromatic hydrocarbons

Environmental Toxicology and Chemistry

Volumn 28, Issue 4, 2009, Pages 759-771

  Carlson, Erik A ^a   Roy, Nirmal K ^b   Wirgin, Isaac I ^b  

^a UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential susceptibility; Fish; Genomics; Microarray; Polychlorinated biphenyls

Indexed keywords

ATLANTIC COASTS; ATLANTIC TOMCODS; ATRIAL NATRIURETIC PEPTIDES; CARDIAC TROPONIN; CATHEPSIN L; CDNA LIBRARIES; CIRCULATORY FAILURES; COPLANAR PCBS; COPLANAR POLYCHLORINATED BIPHENYLS; CRANIOFACIAL; CYTOCHROME P4501A; DIFFERENTIAL SENSITIVITIES; DIFFERENTIAL SUSCEPTIBILITY; DNA SEQUENCING; EARLY LIVES; EXPRESSION PATTERNS; GENOMICS; HALOGENATED AROMATIC HYDROCARBONS; HIGH DOSE; HUDSON RIVERS; MICROARRAY; MICROARRAY ANALYSIS; MIRAMICHI; MOLECULAR BIOMARKERS; NEW YORK , USA; POLYCHLORINATED BIPHENYL MIXTURES; SECOND-GENERATIONS;

AMINES; BIOACTIVITY; GENE EXPRESSION; HALOGENATION; MAMMALS; MICROARRAYS; NUCLEIC ACIDS; POLYCHLORINATED BIPHENYLS; PRINTED CIRCUITS; TOXICITY;

AROMATIC HYDROCARBONS;

AROMATIC HYDROCARBON; ATRIAL NATRIURETIC FACTOR; CATHEPSIN L; CYTOCHROME P450 1A; HALOGENATED HYDROCARBON; POLYCHLORINATED BIPHENYL; TROPONIN;

AROMATIC HYDROCARBON; ARRAY; BIOMARKER; CLONE; EMBRYONIC DEVELOPMENT; ESTUARINE POLLUTION; GADOID; GENE EXPRESSION; HALOGEN; MORTALITY; PCB;

ARTICLE; ATLANTIC COD; BIOACCUMULATION; CARDIOMYOPATHY; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; EMBRYO; GENE EXPRESSION; MICROARRAY ANALYSIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; ATLANTIC OCEAN; CLUSTER ANALYSIS; CYTOCHROME P-450 CYP1A1; DNA, COMPLEMENTARY; EMBRYO, NONMAMMALIAN; GADIFORMES; GENE EXPRESSION PROFILING; GENE LIBRARY; HYDROCARBONS, HALOGENATED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCHLORINATED BIPHENYLS; POLYCYCLIC HYDROCARBONS, AROMATIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

CANADA; HUDSON RIVER; MIRAMICHI RIVER; NEW BRUNSWICK; NEW YORK [UNITED STATES]; NORTH AMERICA; SHINNECOCK BAY; UNITED STATES;

MAMMALIA; MICROGADUS TOMCOD; PISCES;

EID: 64849083857     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/08-195R.1     Document Type: Article

References (40)

1. Wirgin I, Weis JS, McElroy AE. 2006. Physiological and genetic aspect of toxicity in Hudson River species. In Levinton J, Wald-man JR, eds, The Hudson River Ecosystem, Cambridge University Press, New York, NY, USA, pp 441-464.
2. Wirgin I, Chambers RC. 2006. Atlantic tomcod (Microgadus tom-cod ): A model species for the response of Hudson River fish to toxicants. Am Fish Soc Symp 51:331-364.
3. Dey WP, Peck TH, Smith CE, Kreamer G-L. 1993. Epizoology of hepatic neoplasia in Atlantic tomcod (Microgadus tomcod) from the Hudson River estuary. Can J Fish Aquat Sci 50:1897-1907.
4. Fernandez M, Ikonomou M, Courtenay SC, Wirgin I. 2004. Spatial variation and source prediction of PCBs and PCDD/Fs among young-of-the-year and adult tomcod (Microgadus tomcod) in the Hudson River Estuary. Environ Sci Technol 38:976-983.
5. Roy NK, Courtenay S, Yuan Z, Ikonomou M, Wirgin I. 2001. An evaluation of the etiology of reduced CYP1A1 messenger RNA expression in the Atlantic tomcod from the Hudson River, New York, USA, using reverse transcriptase polymerase chain reaction analysis. Environ Toxicol Chem 20:1022-1030.
6. Wirgin I, Grunwald C, Courtenay S, Kreamer G-L, Reichert WL, Stein J. 1994. A biomarker approach in assessing xenobiotic exposure in cancer-prone Atlantic tomcod from the North American Atlantic coast. Environ Health Perspect 102:764-770.
7. Courtenay SC, Grunwald CM, Kreamer G-L, Fairchild WL, Ar-senault JT, Ikonomou M, Wirgin I. 1999. A comparison of the dose and time response of CYP1A1 mRNA induction in chemically treated Atlantic tomcod from two populations. Aquat Toxicol 47:43-69.
8. Yuan Z, Courtenay S, Wirgin I. 2006. Comparison of hepatic and extra hepatic induction of cytochrome P4501A by graded doses of aryl hydrocarbon receptor agonists in Atlantic tomcod from two populations. Aquat Toxicol 76:306-320.
9. Roy NK, Wirgin I. 1997. Characterization of the aromatic hydrocarbon receptor gene and its expression in Atlantic tomcod. Arch Biochem Biophys 344:373-386.
10. Roy NK, Courtney SC, Chambers RC, Wirgin II. 2006. Characterization of the aryl hydrocarbon receptor repressor and a comparison of its expression in Atlantic tomcod from resistant and sensitive populations. Environ Toxicol Chem 25:560-571.
11. Hahn ME. 2002. Aryl hydrocarbon receptor: Diversity and evolution. Chem-Biol Interact 141:131-160.
12. Roy NK, Courtenay SC, Maxwell G, Yuan Z, Chambers RC, Wirgin I. 2002. Cytochrome P4501A1 is induced by PCB77 and benzo[a ]pyrene treatment but not by exposure to the Hudson River environment in Atlantic tomcod (Microgadus tomcod) post-yolk sac larvae. Biomarkers 7:162-173.
13. Helder T. 1981. Effects of 2,3,7,8-tetrachlorodibenzo-p -dioxin (TCDD) on early life stages of rainbow trout (Salmo gairdneri, Richardson). Toxicology 19:101-112.
14. Hornung MW, Spitsbergen JM, Peterson RE. 1999. 2,3,7,8-Tet- rachlorodibenzo-p -dioxin alters cardiovascular and craniofacial development and function in sac fry of rainbow trout (Onco-rhynchus mykiss). Toxicol Sci 47:40-51.
15. Antkiewicz DS, Burns CG, Carney SA, Peterson RE, Heideman W. 2005. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol Sci 84:368-377.
16. Bello SM, Heideman W, Peterson RE. 2004. 2,3,7,8-Tetrachlo-rodibenzo- p -dioxin inhibits regression of the common cardinal vein in developing zebrafish. Toxicol Sci 78:258-266.
17. Dong W, Teraoka H, Tsujimoto Y, Stegeman JJ, Hiraga T. 2004. Role of aryl hydrocarbon receptor in mesencephalic circulation failure and apoptosis in zebrafish embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 77:109-116.
18. Kawamura T, Yamashita I. 2002. Aryl hydrocarbon receptor is required for prevention of blood clotting and for development of vasculature and bone in the embryos of medaka fish, Oryzias latipes. Zool Sci 19:309-319.
19. Prasch AL, Teraoka H, Carney SA, Dong W, Hiraga T, Stegeman JJ, Heideman W, Peterson RE. 2003. Aryl hydrocarbon receptor 2 mediates 2,3,7,8- tetrachlorodibenzo-p -dioxin developmental toxicity in zebrafish. Toxicol Sci 76:138-150.
20. Teraoka H, Dong W, Tsujimoto Y, Iwasa H, Endoh D, Ueno N, Stegeman JJ, Peterson RE, Hiraga T. 2003. Induction of cytochrome P450 1A is required for circulation failure and edema by 2,3,7,8-tetrachlorodibenzo-p -dioxin in zebrafish. Biochem Biophys Res Commun 304:223-228.
21. Schlezinger JJ, Keller J, Verbrugge LA, Stegeman JJ. 2000. 3,3',4,4'-Tetrachlorobiphenyl oxidation in fish, bird, and reptile species: Relationship to cytochrome P450 1A inactivation and reactive oxygen production. Comp Biochem Physiol C Toxicol Pharmacol 125:273-286.
22. Carney SA, Peterson RE, Heideman W. 2004. 2,3,7,8,-Tetrachlo-rodibenzo- p -dioxin activation of the aryl hydrocarbon receptor / aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYPlA-independent mechanism in zebrafish. Mol Pharmacol 66:512-521.
23. Carney SA, Chen J, Burns CG, Xiong KM, Peterson RE, Hiede-man W. 2006. Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish. Mol Pharmacol 70:549-561.
24. Handley-Goldstone HM, Grow MW, Stegeman JJ. 2005. Cardiovascular gene expression profiles of dioxin exposure in zebrafish embryos. Toxicol Sci 85:683-693.
25. Volz DC, Bencic DC, Hinton DE, Law M, Kullman SW. 2005. 2,3,7,8-Tetrachlorodibenzo-p -dioxin (TCDD) induces organ-specific differential gene expression in male Japanese medaka (Oryzias latipes). Toxicol Sci 85:572-584.
26. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N. Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Re-zantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vintsevich A, Trush V, Quackenbush J. 2003. TM4: A free, open-source system for microarray data management and analysis. BioTechniques 34:374-378.
27. Van den Berg M, Birnbaum L, Bosveld ATC, Brunstrom B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van Leeuwen FXR, Liem AKD, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, Tysklìnd M, Younes M, Waern F, Zackarewski T. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106:775-792.
28. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408.
29. Yuan Z, Courtenay SC, Chambers RC, Wirgin I. 2006. Evidence of spatially extensive resistance to PCBs in an anadromous fish of the Hudson River. Environ Health Perspect 114:77-83.
30. Nacci DE, Kohan M, Pelleier M, George E. 2002. Effects of benzo[a ]pyrene exposure on a fish population resistant to the toxic effects of dioxin-like compounds. Aquat Toxicol 57:203-215.
31. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M. Stain-ier DYR. 2002. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 31:106-110.
32. Morita H, Seidman J, Seidman CE. 2005. Genetic causes of human heart failure. J Clin Invest 115:518-526.
33. Lin TM, Ko K, Moore RW, Buchanan DL, Cooke PS, Peterson RE. 2001. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p -dioxin-ex-posed male mice. J Toxicol Environ Health A 64:327-342.
34. Walker MK, Catron TF. 2000. Characterization of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol Appl Pharmacol 167:210-221.
35. Ivniski I, Elmaoued R, Walker MK. 2001. 2,3,7,8-Tetrachloro-dibenzo- p -dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis. Teratology 64:201-212.
36. Incardona JP, Collier TK, Scholz NL. 2004. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 196:191-205.
37. Stypmann J, Glaser K, Roth W, Tobin DJ, Petermann I, Matthias R, Monnig G, Haverkamp W, Breithardt G, Schmahl W, Peters C, Reinheckel T. 2002. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci USA 99:6234-6239.
38. Bruneau BG, Bao ZZ, Fatkin D, Xavier-Neto J, Georgakopoulos D, Maguire CT, Berul CI, Kass DA, Kuroski-de Bold ML, de Bold AJ, Conner DA, Rosenthal N, Cepko CL, Seidman CE, Seidman JG. 2001. Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol Cell Biol 21:1730-1736.
39. Sugden PH, Clerk A. 1998. Cellular mechanisms of cardiac hypertrophy. J Mol Med 76:725-746.
40. Thackaberry EA, Bedrick EJ, Goens MB, Danielson L, Lund AK, Gabaldon D, Smith SM, Walker MK. 2003. Insulin regulation in AhR-null mice: Embryonic cardiac enlargement, neonatal mac-rosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicol Sci 76:407-417.